HomeNews UpdatesHematology Analyzers and Reagents Market worth 5.0 billion USD by 2023

MarketsandMarkets | May 30, 2019
Hematology Analyzers and Reagents Market worth 5.0 billion USD by 2023

The global Hematology Analyzers and Reagents Market is projected to reach USD 4.98 billion by 2023 from USD 3.31 billion in 2018, at a CAGR of 8.5%. The growth in blood donation and the increasing incidence of blood disorders are the major factors driving the growth of the global hematology analyzers and reagents market.

In this report, the hematology analyzers and reagents market has been segmented by product and service; the hematology products & services market is further categorized into price range, end user, and region.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146

The hematology products and services segment is expected to register the highest growth rate during the forecast period

By product and service, the global hematology analyzers and reagents market is segmented into hematology, hemostasis, and immunohematology products and services. The hematology products and services segment is projected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing adoption of POC testing hematology analyzers in emerging economies, rising trend of the ‘reagent rental’ business model, and the availability of a wide range of services from major hematology providers.

Browse and in-depth TOC on "Hematology Analyzers and Reagents Market
76 - Tables
42 - Figures
169 - Pages

Browse More AboutHematology Analyzers and Reagents Market
https://www.marketsandmarkets.com/Market-Reports/hematology-analyzers-reagents-market-153222146.html

Based on end user, the commercial service provider segment accounted for the largest share of the products and services market in 2017

On the basis of end users, the hematology products and services market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research and academic institutes. The commercial service providers segment is expected to be the fastest-growing segment of the market during the forecast period owing to the increasing awareness among individuals for hematology testing, increasing incidence of leukemia and anaemia, shift from manual testing to automated testing, competitive benefits offered by these providers as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management for sample collection), and focus of market players in developing advanced hematology analyzers for the mid- and large-sized laboratories.

North America is expected to dominate the hematology products and services market in 2018

Based on region, the hematology products and services market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest CAGR during the forecast period. Increasing geriatric population coupled with the growing incidence of thalassemia, sickle cell anemia, and leukemia; improved healthcare infrastructure in countries like Japan, China, and Australia; rising number of general surgeries and organ transplantation; and the growing number of ongoing research activities are driving the growth of the hematology products and services market in the Asia Pacific region. In addition, emerging markets such as China, India, and Brazil are expected to offer significant growth opportunities for market players owing to the rising focus on reagent rental business and the presence of large patient pool.

The major players of the global hematology analyzers and reagents market are Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland).

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com

Share this story

How can we help you?

To discuss how our team can help you and your business achieve true results,
Get in touch with us

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved